The study was transported to determine the the most prudent and most effective drug among differing categories of antagonistic-hypertensive drugs to treat hypertension in patients accompanying various cardiovascular afflictions. Hypertension is a condition with persistent promotion of Blood Pressure in arteries. It is the second superior cause of death. The complex interplay of genes and environmental determinants results in hypertension. Severe headache, drowsiness, view problems, nosebleed, fatigue, and disorientation are among the syndromes. It can cause a variety of cardiovascular questions, including myocardial infarction, heart failure artery ailment, and heart failure. The situation of Hypertension can be done by Anti-Hypertensive Drugs that include Angiotensin-II Receptor Blockers, Beta Blockers, Angiotensin Converting Enzyme Inhibitors, etc. The study complicated a sample size of 220 at a distance which 100 were Myocardial Infarction subjects,100 were coronary artery ailment patients and 20 were Heart Failure cases. Angiotensin-II Receptor Blockers, Beta Blockers, and Angiotensin Converting Enzyme Inhibitors were the antihypertensive drugs chosen for the study. Angiotensin-II Receptor Blockers were recommended to 31 Myocardial Infarction patients, 31 heart failure artery disease subjects, and 8 Heart Failure patients. Beta Blockers were arbitrary to 58 patients accompanying myocardial infarction, 58 victims with coronary channel disease, and 7 victims with heart attack. Angiotensin Converting.Enzyme Inhibitors were prescribed to 10 Myocardial Infarction patients,10 Coronary Artery Disease sufferers, and 5 Heart Failure patients. The study disclosed an outcome at which point Beta Blockers were observed expected the drugs with maximum efficacy and maximum security.
Author(s) Details:
R. E. Ugandar,
Department
of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal-518501, Kurnool
District, Andhra Pradesh, India.
Umadevi
Iluru,
Department
of Neurology, Santhiram Medical College and General Hospital, NH-40,
Venkateswarapuram-518112, Panyam (M), Nandyal District, Andhra Pradesh, India.
Mariamma Bethe,
Department of Critical Care Medicine, Santhiram Medical College and
General Hospital, NH-40, Venkateswarapuram-518112, Panyam (M), Nandyal
District, Andhra Pradesh, India.
C. Bhargava Reddy,
Department of Pharmacy Practice, Santhiram College of Pharmacy,
Nandyal-518501, Kurnool District, Andhra Pradesh, India.
A.
Sai Keshava Reddy,
Department
of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal-518501, Kurnool
District, Andhra Pradesh, India.
Kiran
C. Nilugal,
School
of Pharmacy, Management and Science University Shah Alam. Malaysia.
Nagashekhara Molugulu,
School of Pharmacy, Monash University, Jalan Lagoon Selatan, Bandar
Sunway, 47500 Subang Jaya, Selangor, Malaysia.
Venkata Ramana Baru,
Department of Pharmacy Practice, Santhiram College of Pharmacy,
Nandyal-518501, Kurnool District, Andhra Pradesh, India.
K. Anusha,
Department of Pharmacy Practice, Santhiram College of Pharmacy,
Nandyal-518501, Kurnool District, Andhra Pradesh, India.
Please see the link here: https://stm.bookpi.org/COPS-V4/article/view/9304
No comments:
Post a Comment